Publication | Closed Access

Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport

Metabolic SyndromeOxysterolLow BioavailabilityBiochemistryLipid SynthesisMedicineCurcumin-3,4-dichloro Phenyl PyrazoleReverse Cholesterol TransportPharmacologyDrug Discovery